Loading...
Loading...
Browse all stories on DeepNewz
VisitPrimary measure of success for GPT-4b-Micro in longevity research by end of 2025?
Increased lifespan • 25%
Improved cellular health • 25%
Reduced disease incidence • 25%
Other • 25%
Research papers or official statements from OpenAI or Retro Biosciences
OpenAI Develops GPT-4b-Micro AI Model with Retro Biosciences to Enhance Longevity Research, Achieving 50 Times Greater Effectiveness
Jan 17, 2025, 04:00 PM
OpenAI has developed a new AI model, named GPT-4b-micro, in collaboration with Retro Biosciences, a longevity startup funded by Sam Altman. This model is designed to enhance the reprogramming of cells by providing suggestions on how to re-engineer Yamanaka factors, which are crucial for cellular reprogramming. The collaboration aims to extend human life, with the model reportedly allowing researchers to modify two of the Yamanaka factors to achieve over 50 times greater effectiveness. The initiative reflects OpenAI's broader commitment to advancing longevity science through innovative bioengineering solutions.
View original story
3-5 discoveries • 25%
More than 8 discoveries • 25%
6-8 discoveries • 25%
0-2 discoveries • 25%
Other • 25%
Healthcare • 25%
Agriculture • 25%
Energy • 25%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Proven effective with moderate lifespan extension • 25%
No significant effect on lifespan • 25%
Negative effects or halted trials • 25%
Proven effective with significant lifespan extension • 25%
Stem cell therapy • 25%
Cancer research • 25%
Neurodegenerative diseases • 25%
Longevity research • 25%
No • 50%
Yes • 50%